Karriereverlauf von Jose Menoyo
Ehemalige bekannte Positionen von Jose Menoyo
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SHIELD THERAPEUTICS PLC | Technik-/Wissenschafts-/F&E-Leiter | 27.09.2021 | 02.01.2023 |
ALEXION PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.05.2018 | 01.07.2021 |
ZS PHARMA INC | Technik-/Wissenschafts-/F&E-Leiter | 19.02.2015 | 01.06.2017 |
Ausbildung von Jose Menoyo
University of Puerto Rico | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 3 |
Vereinigtes Königreich | 2 |
Operativ
Chief Tech/Sci/R&D Officer | 3 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
SHIELD THERAPEUTICS PLC | Health Technology |
Private Unternehmen | 2 |
---|---|
ZS Pharma, Inc.
ZS Pharma, Inc. Pharmaceuticals: MajorHealth Technology ZS Pharma, Inc. engages in the development of development and commercialization of non-absorbed drugs to treat renal, cardiovascular, liver and metabolic diseases. It develops treatment of hyperkalemia. It also focuses on clinical development, novel technology, and clinical trials. The company was founded by Alvaro F. Guillem and Donald Jeffrey Keyser on February 5, 2008 and is headquartered in San Mateo, CA. | Health Technology |
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
- Börse
- Insiders
- Jose Menoyo
- Erfahrung